BIOMAT Database Logo BIOMAT Database Logo

[Response of hGH to insulin hypoglycemia and to bromocriptine before and after the administration of L-dopa in primary hypothyroidism]. 1985

C Campino, and H Pumarino, and H Michelsen, and P Piraino, and G Generini, and B Bruggendieck

UI MeSH Term Description Entries
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C Campino, and H Pumarino, and H Michelsen, and P Piraino, and G Generini, and B Bruggendieck
[Growth hormone secretion after oral administration of L-dopa in primary hypothyroidism].
January 1979, Endokrynologia Polska,
C Campino, and H Pumarino, and H Michelsen, and P Piraino, and G Generini, and B Bruggendieck
[HGH response to dihydroxyphenylalanine (L-dopa) (author's transl)].
January 1976, Anales espanoles de pediatria,
C Campino, and H Pumarino, and H Michelsen, and P Piraino, and G Generini, and B Bruggendieck
[Behavior of HGH after oral administration of L-dopa in normal and obese subjects].
August 1974, Bollettino della Societa italiana di biologia sperimentale,
C Campino, and H Pumarino, and H Michelsen, and P Piraino, and G Generini, and B Bruggendieck
HGH response to insulin-induced hypoglycemia in healthy and obese subjects.
March 1973, The Keio journal of medicine,
C Campino, and H Pumarino, and H Michelsen, and P Piraino, and G Generini, and B Bruggendieck
[HGH response to insulin-induced hypoglycemia in healthy subjects and obesity].
September 1972, Nihon Naibunpi Gakkai zasshi,
C Campino, and H Pumarino, and H Michelsen, and P Piraino, and G Generini, and B Bruggendieck
[Effects of adrenergic blocking agents on HGH secretion after administration of L-Dopa].
December 1975, Bollettino della Societa italiana di biologia sperimentale,
C Campino, and H Pumarino, and H Michelsen, and P Piraino, and G Generini, and B Bruggendieck
[Effects of intravenous lipid loading on HGH secretion after administration of L-DOPA].
May 1979, Minerva medica,
C Campino, and H Pumarino, and H Michelsen, and P Piraino, and G Generini, and B Bruggendieck
[Normalization of the GH response to L-DOPA in acromegalics after treatment with bromocriptine].
January 1979, Archivio per le scienze mediche,
C Campino, and H Pumarino, and H Michelsen, and P Piraino, and G Generini, and B Bruggendieck
[Inhibition by L-DOPA of the hypothalamo-hypophyseo-adrenocortical response to insulin hypoglycemia in man].
July 1974, Bollettino della Societa italiana di biologia sperimentale,
C Campino, and H Pumarino, and H Michelsen, and P Piraino, and G Generini, and B Bruggendieck
[Response of growth hormone (HGH) to L-dopa, L-arginine and their combination in normal individuals].
January 1982, Medicina clinica,
Copied contents to your clipboard!